ANXIOLYTIC-LIKE EFFECTS OF BIOTECHNOLOGICAL PREPARATION ROPREN® IN β-AMYLOID-(25-35) RAT MODEL OF ALZHEIMER'S DISEASE IN FEMALE RATS WITH EXPERIMENTAL MODEL OF MENOPAUSE